Verastem (VSTM) Accumulated Expenses (2018 - 2025)
Verastem has reported Accumulated Expenses over the past 8 years, most recently at $54.0 million for Q4 2025.
- Quarterly results put Accumulated Expenses at $54.0 million for Q4 2025, up 16982.59% from a year ago — trailing twelve months through Dec 2025 was $54.0 million (up 16982.59% YoY), and the annual figure for FY2025 was $54.0 million, up 16982.59%.
- Accumulated Expenses for Q4 2025 was $54.0 million at Verastem, up from $44.7 million in the prior quarter.
- Over the last five years, Accumulated Expenses for VSTM hit a ceiling of $54.0 million in Q4 2025 and a floor of $3000.0 in Q4 2021.
- Median Accumulated Expenses over the past 5 years was $3.1 million (2021), compared with a mean of $10.6 million.
- Biggest five-year swings in Accumulated Expenses: crashed 99.95% in 2021 and later soared 499333.33% in 2022.
- Verastem's Accumulated Expenses stood at $3000.0 in 2021, then soared by 499333.33% to $15.0 million in 2022, then rose by 19.66% to $17.9 million in 2023, then plummeted by 98.24% to $316000.0 in 2024, then soared by 16982.59% to $54.0 million in 2025.
- The last three reported values for Accumulated Expenses were $54.0 million (Q4 2025), $44.7 million (Q3 2025), and $5.8 million (Q2 2025) per Business Quant data.